The Latest Breaking News from Steve Reitmeister

Big-box retailer Target (TGT) has witnessed solid bottom-line growth in the last reported quarter, despite lagging sales. So, is TGT worth buying now? Read on.

Despite several macroeconomic headwinds, the beverage sector has consistently thrived due to demand surges for its products and is anticipated to maintain its upward trajectory. Given this backdrop, let us determine which beverage stocks among PepsiCo (PEP), Anheuser-Busch InBev SA/NV (BUD), and Coca-Cola Consolidated (COKE) are worth buying, selling or…

Despite strict consumption regulations, the tobacco industry's momentum endures, owing to consistent demand, new product innovations, and extensive advertising. Hence, investors could add fundamentally sound tobacco stocks British American Tobacco (BTI), Japan Tobacco (JAPAY), and Imperial Brands (IMBBY) to their portfolios today. Continue reading….

Social media giant Meta Platforms’ (META) robust performance, unwavering commitment to innovation, and delivering value to its vast user base have been instrumental in its continued success. Considering the trajectory META is tracing, let’s determine if you should be bullish or bearish on this stock. Read more….

Amid the persistent macroeconomic challenges, American Airlines (AAL) made significant strides to strengthen its financial position. So, is this the right time to load up on AAL shares? Let’s evaluate some of its key financial metrics to gauge its prospects.

The industrial metals sector’s outlook seems robust, driven by soaring demand for metals and minerals amid rising infrastructure development, increased urbanization, and rapid clean energy transition. Thus, it could be wise to buy quality industrial stocks BHP Group (BHP), Southern Copper (SCCO), and Marubeni Corp. (MARUY), which have been attracting…

While macroeconomic headwinds have impacted the IT sector, its long-term prospects appear promising, and we think tech stocks BlackBerry (BB), Ribbon Communications (RBBN), and Aviat Networks (AVNW) could be worth watching for growth. Keep reading.

The pharma industry is poised for long-term growth supported by increasing demand for drugs worldwide and technological advancements. While leading pharma stocks Collegium Pharmaceutical (COLL) and Canopy Growth (CGC) should benefit from the industry tailwinds, let us determine which is the better buy.

Rapid urbanization and demand for smart entertainment should bolster long-term growth in the entertainment industry. While the industry outlook may seem promising, should one buy, hold or sell Endeavor Group (EDR), Live Nation Entertainment (LYV), and fuboTV (FUBO)? Read more to find out.